Merck, Microsoft and Sun Microsystems have joined the customer advisory board of FXall, the bank-backed global portal for online foreign exchange trading.
FXall’s customer advisory board – which recently convened for a meeting in London to discuss future developments for the portal - is closely involved in shaping FXall’s product offering. Board members also play a key role in advising on issues of connectivity, integration and security.
"FXall already has the most comprehensive functionality in the marketplace" says Lisa Evren, treasurer of Sun Microsystems. "The challenge now is to extend the benefits of electronic trading to as wide a group of users as possible. We look forward to taking a leading role in this development."
The addition of Merck to the advisory board comes six months after the global pharmaceutical giant agreed to take a similar position at defunct competitor portal Atriax. The Atriax platform was shut down by its founders Citibank, Deutsche Bank, and JPMorgan Chase in early April, leaving the way clear for FXall to battle it out with States Street's FX Connect service and the remaining independent price discovery portal Currenex.
FXall says it now has more than 250 customers signed for trading, an increase of 60% in the last quarter alone.